dihydroxy gymnemic triacetate
structure in first source
relevant articles (0 outcomes,
Bio-Agent Context: Research Results
|1. ||Prostatic Neoplasms (Prostate Cancer)
|2. ||Body Weight (Weight, Body)
- "An optimum dose of dihydroxy gymnemic triacetate (20mg/kg body weight) was orally administered for 45 days to streptozotocin diabetic rats for the assessment of plasma glucose, insulin, glycated hemoglobin (HbA1c), tissue glycogen, lipid parameters such as triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol and activities of hepatic marker enzymes, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and acid phosphatase (ACP) in normal and streptozotocin diabetic rats.
Related Drugs and Biologics